Patient Clinical Summary - Morning Rounds (12/07/26, 8:00 AM)

Vitals

Primary Diagnosis

• Patient is conscious and oriented
• General condition: fair, no pallor
• Systemic examination: within normal limits

Clinical Interpretation - What This Patient Likely Has

1. Diabetes with Foot Complication (Core Problem)

• INJ. HA (Humalog/Human Actrapid) - 16/14/16 units before meals: Short-acting insulin for meal-time coverage
• INJ. NPH - 10/8/10 units: Intermediate-acting basal insulin
• GRBS charting every 6 hours: Active glucose monitoring indicating poorly controlled or insulin-dependent diabetes
• Watch for hypoglycemia: High insulin doses require vigilance
• The non-healing ulcer + gangrene on the 5th toe is the classic presentation of diabetic foot, where peripheral neuropathy and ischemia prevent wound healing

2. Antibiotic Therapy (Wound Infection)

• T. Bactrim DS (Trimethoprim-Sulfamethoxazole) 1-0-1, Day 3: A broad-spectrum antibiotic commonly used for skin/soft tissue infections in diabetic foot. Now on Day 3, indicating treatment is ongoing

3. Peripheral Vascular Disease / Peripheral Arterial Disease

• Tab. Stiloz (Cilostazol) 50 mg twice daily: A phosphodiesterase-3 inhibitor that improves blood flow to the limbs - specifically used in peripheral arterial disease and intermittent claudication, very relevant to diabetic foot
• Tab. Ecospirin (Aspirin) 75 mg: Antiplatelet therapy - standard for cardiovascular and peripheral vascular disease prevention
• Tab. Atorva (Atorvastatin) 40 mg at night: Statin for dyslipidemia, which is a major risk factor for atherosclerosis and peripheral vascular disease
• Calf muscle exercises: Promotes peripheral circulation
• Propped up position: Wound care and circulation management

4. Respiratory Condition (COPD or Asthma)

• Neb. Duolin (Ipratropium + Levosalbutamol) 3x/day: A bronchodilator combination (anticholinergic + beta-2 agonist) used for airflow obstruction
• Neb. Budecort (Budesonide) twice daily: Inhaled corticosteroid for airway inflammation control
• Together, these strongly suggest COPD or asthma as a co-morbidity

5. Gastroprotection

• INJ. Pantoprazole (Pantop) 40 mg IV once daily: Proton pump inhibitor - protects the gastric mucosa from ulceration, especially given the concurrent use of aspirin and antibiotics

6. Pain / Fever Management

• INJ. PMOL 1g (Paracetamol/Acetaminophen) IV 3x/day: For pain and fever management post-operatively/post-debridement

7. Anti-emetic

• INJ. Emeset (Ondansetron) 4 mg IV SOS: For nausea and vomiting as needed - possibly related to medications or post-procedure

8. Likely Heart Failure / Fluid Retention

• Tab. Aldactone (Spironolactone) 25 mg: A potassium-sparing diuretic and anti-aldosterone agent. Used in heart failure, ascites, or as an adjunct antihypertensive - suggests possible cardiac involvement or fluid overload

Overall Clinical Picture

1. Diabetes Mellitus (insulin-dependent or poorly controlled) - the root cause
2. Diabetic foot - non-healing ulcer with gangrene requiring surgical intervention (amputation + debridement)
3. Peripheral arterial/vascular disease - impaired limb circulation contributing to non-healing
4. Dyslipidemia - cardiovascular risk factor on statin + aspirin
5. COPD or Asthma - managed with bronchodilators and inhaled steroid
6. Possible heart failure or fluid retention - Spironolactone use
7. Active wound infection - on antibiotic Bactrim DS

Note: This interpretation is based on the medications and clinical notes visible in the chart. The full diagnosis should be confirmed with the complete patient history, investigations, and attending physician's assessment.

Can INJ. NPH Be Given TID?

Standard NPH Dosing

"It may be given once or twice daily. Since the action profile of NPH insulin does not cover 24 hours, a twice-daily dose in the morning and evening or bedtime is the recommended regimen."

Why TID Is Not Appropriate for NPH

1. Duration of action overlap - NPH lasts up to 24 hours. A TID schedule (morning, afternoon, night) would cause insulin stacking - doses overlapping before the previous one wears off, dramatically increasing hypoglycemia risk.
2. It is a basal insulin - NPH is meant to provide background coverage, not meal-time control. TID dosing blurs it into something it is not pharmacologically designed to be.
3. No guideline support - The ADA, WHO, and standard insulin algorithms do not recommend TID for NPH.

What the Chart Actually Shows

INJ. NPH — 10 - 8 - 10

Better Alternatives

• Insulin Glargine (Lantus) - once daily, no peak, lower hypoglycemia risk
• Insulin Detemir (Levemir) - once or twice daily, more predictable profile

What Does "EDTA Sensitive" Mean on a C&S Report?

• NDM (New Delhi Metallo-beta-lactamase) - most prevalent in South Asia
• VIM (Verona Integron-Mediated)
• IMP (Imipenemase)

Can You Switch From Tigecycline?

Tigecycline's Limitations in This Case

Recommended Antibiotic Options for MBL-Producing Organisms

Preferred (New Agents)

Accessible Options (Older Agents - check your C&S sensitivities)

Practical Recommendation for Your Patient

1. Check if the C&S report lists individual antibiotic sensitivities alongside the EDTA result. The MBL flag tells you the mechanism - the drug sensitivities tell you what still works against this specific isolate.
2. If Colistin is reported sensitive - switch to INJ. Colistin (most accessible MBL-active agent in South Asia). Monitor renal function closely given the patient is a diabetic.
3. If available, Cefiderocol is the gold standard for MBL infections.
4. Continue Bactrim DS - it covers MRSA/skin flora and is not affected by MBL mechanisms (MBLs only target beta-lactams).
5. Do not use carbapenems (Meropenem, Imipenem) - MBL organisms are carbapenem-resistant by definition. EDTA sensitivity = carbapenem resistance.

Key point: EDTA sensitivity = MBL producer = carbapenem-resistant organism. Tigecycline can continue as a combination partner but should not be relied on as monotherapy in a serious wound infection. Escalate to Colistin or a newer agent based on your full C&S panel, and involve an infectious disease specialist if possible.